BFM
GMAB icon

Boothbay Fund Management’s Genmab GMAB Stock Holding History

Boothbay Fund Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Buy
+40,048
New +$1.2M 0.01% 906
2025
Q4 		– Sell
-63,700
Closed -$1.95M – 2101
2025
Q3 		$1.95M Buy
+63,700
New +$1.55M 0.03% 576

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Boothbay Fund Management's GMAB Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Genmab (GMAB) in Q1 2026: 40,048 shares worth $1.07M. The stake represents 0.01% of the portfolio and ranks #906 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in GMAB as recently as Q3 2025.

Boothbay Fund Management first reported a position in GMAB in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.95M in Q3 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Boothbay Fund Management held 40,048 shares of Genmab worth $1.07M as of Q1 2026.
  • Genmab was a new Boothbay Fund Management position in Q1 2026.
  • Genmab made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #906 holding.
  • Boothbay Fund Management first reported a position in Genmab in Q3 2025 and has held it in 2 quarters since.
  • Boothbay Fund Management's Genmab position peaked at $1.95M in Q3 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.